Ibrahim B. Dagher insider trades

Open-market stock purchases and sales by Ibrahim B. Dagher, Director at Brainstorm Cell Therapeutics Inc, from SEC Form 4 filings since Jul 19, 2024.

Recent trades

DateStockTradeValue
Feb 26, 2026BCLI Brainstorm Cell Therapeutics IncBought (not open market)$158K

Companies traded

  • BCLI Brainstorm Cell Therapeutics Inc: 1 sale, last Feb 26, 2026

Get free alerts when Ibrahim B. Dagher files a new trade →